LordCRisiS. Frameworks and methods in diagnosing autism spectrum disorder. Ment Retard Dev Disabil Res Rev1998; 4:90–6.
2.
KannerL. Autistic disturbances of affective contact. Nerv Child1943; 2:217–50.
3.
FombonneE. The epidemiology of autism: a review. Psychol Med1999; 29:769–86.
4.
GillbergCWingL. Autism: not an extremely rare disorder. Acta Psychiatr Scand1999; 99:399–406.
5.
MilesJHHillmanRE. Value of a clinical morphology examination in autism. Am J Med Genet2000; 91:245–53.
6.
ChakrabartiSFombonneE. Pervasive developmental disorders in preschool children. JAMA2001; 285:3093–9.
7.
BairdGCharmanTBaron-CohenSCoxASwettenhamJWheelwrightSDrewA. A screening instrument for autism at 18 months of age: a 6-year follow up study. J Am Acad Child Adolesc Psychiatry2000; 39:694–702.
8.
BertrandJMarsABoyleCBovefYeargin-AllsoppMDecoufleP. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics2001; 108:1155–61.
9.
Department of Education (US). Twenty-second annual report to Congress on the implementation of the Individuals with Disabilities Education Act. Jessup (MD): US Department of Education; 2000.
10.
California Health and Human Services Agency. Changes in the population of persons with autism and pervasive developmental disorders in California's Developmental Services System: 1987 through 1998 A report to the legislature. Sacramento: CHHS, Department of Developmental Services; 1999.
11.
FombonneE. Is there an epidemic of autism?Pediatrics2001; 107:411–2.
12.
CroenLAGretherJKHoogstrateJSelvinS. The changing prevalence of autism in California. J Autism Dev Disord2002; 32:207–15.
13.
ByrdRS. Report to the legislature on the principal findings from the epidemiology of autism in California: a comprehensive pilot study. Davis (CA): M.I.N.D.Institute, University of California, Davis; 2002.
14.
California Department of Developmental Services. Autism spectrum disorders—changes in the California caseload. An update: 1999 through 2002. Sacramento: CDDS; 2003.
15.
Yeargin-AllsoppMRiceCKarapurkarTDoernbergNBoyleCMurphyC. Prevalence of autism in a US metropolitan area. JAMA2003; 289:49–55.
16.
FombonneEDu MazaubrunCCansCGrandjeanH. Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry1997; 36:1561–9.
17.
GillbergCColemanM. Autism and medical disorders: a review of the literature. Dev Med Child Neurol1996; 38:191–202.
18.
BartonMVolkmarF. How commonly are known medical conditions associated with autism?J Autism Dev Disord1998; 27:273–8.
19.
RutterM. Autistic children: infancy to adulthood. Semin Psychiatry1970; 2:435–50.
20.
GillbergCSteffenburgS. Outcome and prognostic factors in infantile autism and similar conditions: a population-based study of 46 cases followed through puberty. J Autism Dev Disord1987; 17:273–87.
21.
National Research Council, Committee on Educational Interventions for Children with Autism. Educating children with autism. Washington: National Academy Press2001.
22.
RogersSJ. Brief report: early intervention in autism. J Autism Dev Disord1996; 26:243–6.
23.
BuitelaarJKWillemsen-SwinkelsSH. Medication treatment in subjects with autistic spectrum disorders. Eur Child Adolesc Psychiatry2000; 9Suppl 1:I85–I97.
24.
LewisMH. Brief report: psychopharmacology of autism spectrum disorders. J Autism Dev Disord1996; 26:231–5.
25.
JarbrinkKKnappM. The economic impact of autism in Britain. Autism2001; 5:7–22.
26.
GreschwindSA. The economic burden of autism. Los Angeles: The Cure Autism Now Foundation; 2000.
27.
HoneycuttADunlapLChenHal HomsaiG. The cost of developmental disabilities. Task Order No. 0621-09. Revised final report. Research Triangle Park (NC): Research Triangle Institute; 2000.
28.
FilipekPAAccardoPJAshwalSBaranekGTCookEHJrDawsonG. Practice parameter: screening and diagnosis of autism. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 2000; 55:468–79.
29.
TeitelbaumPTeitelbaumONyeJFrymanJMaurerRG. Movement analysis in infancy may be useful for early diagnosis of autism. Proc Natl Acad Sci USA1998; 95:13982–7.
30.
NelsonKBGretherJKCroenLADambrosiaJMDickensBFJelliffeLL. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol2001; 49:597–606.
31.
SteffenburgSGillbergCHellgrenLAnderssonLGillbergICJakobssonGBohmanM. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry1989; 30:405–16.
32.
FolsteinSRutterM. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry1977; 18:297–321.
33.
BaileyALe CouteurAGottesmanIBoltonPSimonoffEYuzdaERutterM. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med1995; 25:63–77.
34.
RitvoERFreemanBJMason-BrothersAMoARitvoAM. Concordance for the syndrome of autism in 40 pairs of afflicted twins. Am J Psychiatry1985; 142:74–7.
35.
PhilippeAMartinezMGuilloud-BatailleMGillbergCRastamMSponheimE. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet1999; 8:805–12.
36.
A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. International Molecular Genetic Study of Autism Consortium. Am J Hum Genet2001; 69:570–81.
37.
RischNSpikerDLotspeichLNouriNHindsDHallmayerJ. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet1999; 65:493–507.
38.
Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum Mol Genet2001; 10:973–82.
39.
FolsteinSERosen-SheidleyB. Genetics of autism: complex aetiology for a heterogenous disorder. Nat Rev Genet2001; 2:943–55.
40.
StokstadE. New hints into the biological basis of autism. Science2001; 294:34–7.
41.
AndresC. Molecular genetics and animal models in autistic disorder. Brain Res Bull2002; 57:109–19.
42.
PersicoAMD'AgrumaLMaioranoNTotaroAMiliterniRBravaccioC. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry2001; 6:150–9.
43.
IngramJLStodgellCJHymanSLFiglewicaDAWeitkampLRRodierPM. Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology2000; 62:393–405.
44.
SkuseDH. Imprinting, the X-chromosome, and the male brain: explaining sex differences in the liability to autism. Pediatr Res2000; 47:9–16.
45.
JohnsonWG. DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disorders. Am J Med Genet1999; 88:311–23.
46.
LondonEA. The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect2000;108Suppl 3:401–4.
47.
KemperTLBaumanM. Neuropathology of infantile autism. J Neuropathol Exp Neurol1998; 57:645–52.
48.
RodierPMIngramJLTisdaleBNelsonSRomanoJ. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol1996; 370:247–61.
49.
RapinI. Autism. N Engl J Med1997; 337:97–104.
50.
ZimmermanAWGordonB. Neural mechanisms in autism. In: AccardoAMMagnusenCCaputeAJ, editors. Autism: clinical and research issues. Baltimore: York Press; 2000.
51.
EatonWWMortensenPBThomsenPHFrydenbergM. Obstetric complications and risk for severe psychopathology in childhood. J Autism Dev Disord2001; 31:279–85.
52.
DeykinEYMacMahonB. Viral exposure and autism. Am J Epidemiol1979; 109:628–38.
53.
PivenJSimonJChaseGAWzorekMLandaRGayleJFolsteinS. The etiology of autism: pre-, peri-, and neonatal factors. J Am Acad Child Adolesc Psychiatry1993; 32:1256–63.
54.
RodierPMHymanSL. Early environmental factors in autism. Ment Retard Dev Disabil Res Rev1998; 4:121–8.
55.
IngramJLPeckhamSMTisdaleBRodierPM. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol2000; 22:319–24.
56.
RodierPM. The early origins of autism. Sci Am2000; 282:56–63.
57.
Agency for Toxic Substances and Disease Registry (US), Division of Toxicology, Emergency Response and Scientific Assessment Branch. Chemical specific consultation: hazardous substance exposures and autism. Atlanta: ATSDR; 1999.
58.
WakefieldAJMurchSHAnthonyALinnellJCassonDMMalikM. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet1998; 351:637–41.
59.
BernardSEnayatiARedwoodLRogerHBinstockT. Autism: a novel form of mercury poisoning. Med Hypotheses2001; 56:462–71.
60.
Medical Research Council. MRC review of autism research: epidemiology and causes. London (UK): Medical Research Council; 2001.
61.
Yeates-FrederikxMHNijmanHLogherEMerckelbachHL. Birth patterns in mentally retarded autistic patients. J Autism Dev Disord2000; 30:257–62.
62.
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee. StrattonKGableAShettyPMcCormickM, editors. Immunization safety review: measles-mumps-rubella vaccine and autism. Washington: National Academy Press2001.
63.
MadsenKHviidAVestergaardMSchendelDWohlfahrtJThorsenP. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med2002; 347:1477–82.
64.
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee. StrattonKGableAMcCormickMC, editors. Immunization safety review: thimerosal-containing vaccines and neurodevelopmental disorders. Washington: National Academy Press2001.
65.
RitvoERFreemanBJPingreeCMason-BrothersAJordeLJensonWL. The UCLA-University of Utah epidemiologic survey of autism: prevalence. Am J Psychiatry1989; 146:194–9.
66.
SmalleySLAsarnowRFSpenceMA. Autism and genetics. A decade of research. Arch Gen Psychiatry1988; 45:953–61.
67.
SimonoffE. Genetic counseling in autism and pervasive developmental disorders. J Autism Dev Disord1998; 28:447–56.
68.
KhouryMJThrasherJFBurkeWGettigEAFridingerFJacksonR. Challenges in communicating genetics: a public health approach. Genet Med2000; 2:198–202.